New research from the University of Liverpool has identified the role of a specific protein in the human body that can help prevent the survival and spread of eye cancer, by initiating cancer ‘cell-suicide’.
The new findings may help revolutionise the approach to metastatic uveal melanoma (UM) – a cancer that arises from the pigment cells (melanocytes) in the eye, and for which there is currently no effective treatment.
Metastasis is the spread of a cancer or other disease from one organ or part of the body to another without being directly connected with it. This occurs in about half of the patients with UM.
Although rare, UM is the most common primary eye cancer in adults. While the primary tumour can often be treated very effectively, up to 50% of patients develop metastases most often in the liver, for whom no effective therapy is available.
Programmed cell death
Apoptosis, or programmed cell death, is a rapid and irreversible process to efficiently eliminate dysfunctional cells. A hallmark of cancer is the ability of malignant cells to evade apoptosis.
Dr Luminita Paraoan, from the University’s Department of Eye and Vision Science in the Institute of Ageing and Chronic Disease, has published new findings in the British Journal of Cancer that identify the requirement of a protein called p63 for the initiation of apoptosis in UM.
Chromosome 3 is one of the 23 pairs of chromosomes in humans. People normally have two copies of each chromosome. One part of chromosome 3 contains the gene for the protein p63. Unfortunately people with aggressive (resistant to apoptosis) UM do not have this part and therefore do not have the p63 protein.
Dr Paraoan’s research found that if the p63 gene is used in combination with another gene, called p53, they can effectively target UM and start the process of apoptosis in the cancerous cells.
Tumour suppressor genes
The p53 gene is from a class of genes called tumour suppressors which are mutated in cases of cancer. Tumour suppressor genes are protective genes. Normally, they limit cell growth by monitoring how quickly cells divide into new cells, repairing damaged DNA, and controlling when a cell dies.
When a tumour suppressor gene is mutated, for example in cancer cases, cells grow uncontrollably and may eventually form a mass called a tumour. Therefore p53 itself is ineffective in starting the process of apoptosis of cancer calls in UM.
Of her research Dr Luminita said: “The study highlights for the first time the requirement of p63 in the initiation of apoptosis in UM”.
“Our findings have broad-ranging implications for other cancers in which apoptosis is evaded or is problematic. They will hopefully prove advantageous in designing therapeutic approaches to cancerous tumours that are currently resistant to chemotherapy and radiotherapy.”
Receive an email update when we add a new CANCER TREATMENT article.
The Latest on: Eye cancer treatment
via Google News
The Latest on: Eye cancer treatment
- Karl was treated for prostate cancer in 2005 and then i…on May 25, 2020 at 4:02 am
Karl was treated for prostate cancer in 2005 and then in February 2010 announced he had neck cancer, which forced him to take a leave of absence from the Nuggets for treatment and miss the ...
- Coronavirus Treatment: The Next Great Cure Might Be Hiding In Your Medicine Cabineton May 23, 2020 at 5:30 am
Discovering fresh ways to utilize existing drugs requires policies that encourage researchers to look for them in the first place.
- In photos: For this cancer patient, lockdown means a 50-km trip for chemo, fear of being ostracisedon May 22, 2020 at 7:04 pm
Amidst this gruelling lockdown imposed to slow the spread of Covid, 32-year-old Aditi (name changed) has to step out of her apartment in Andheri, Mumbai, fo. On Marc ...
- New analytic tool designed to help guide precision oncology discovery and treatmentson May 19, 2020 at 1:18 pm
Recent large-scale efforts to categorize the molecular data of multiple cancer types has yielded so much information that researchers now have a new question: How to turn all this data into meaningful ...
- Qld researchers unlock some of the mysteries of rare eye melanomas, paving the way for better treatmentson May 18, 2020 at 11:19 pm
QUEENSLAND researchers have unlocked some of the mysteries surrounding a rare form of melanoma in the eye, hopefully paving the way for the development of more effective treatments.
- Study Finds New Clues In Eye Canceron May 18, 2020 at 2:23 pm
About five per cent of melanomas in the eye are caused by exposure to sunlight, while the majority are not, a new study by QIMR Berghofer and Queensland Ocular Oncology Service has found. The findings ...
- Mum discovers toddler's rare aggressive cancer from looking at photographson May 18, 2020 at 12:08 am
Lauren Barker, 22, first saw a white reflex, rather than common red-eye, shining from her son Frankie’s left pupil when he was four months old ...
- Mum discovers son’s discoloured eye in photographs was a sign of a rare and aggressive canceron May 16, 2020 at 3:41 am
Mum Lauren is urging parents to go to their doctors if they notice anything strange about their children's eyes.
- From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaqon May 15, 2020 at 7:17 am
Legend Biotech, a cancer cell therapy developer with roots in China, is preparing for a US stock exchange listing as its lead candidate keeps pace in the ...
via Bing News